Parathyroid gland disorder
MONDO:0001223A disease involving the parathyroid gland.
Also known as: disease of parathyroid gland, disease or disorder of parathyroid gland, disorder of parathyroid gland, parathyroid disease, parathyroid gland disease, parathyroid gland disease or disorder, parathyroid gland diseases, parathyroid gland disorder
164 clinical trials for this condition and its sub-types, 14 tagged with Parathyroid gland disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Parathyroid gland disorder
-
Hyperparathyroidism 8 trials · 89 incl. sub-types
4 sub-types
- Primary hyperparathyroidism 23 trials · 56 incl. sub-types Sub-types →
- Hereditary hyperparathyroidism 1 trial · 35 incl. sub-types Sub-types →
- Secondary hyperparathyroidism 19 trials · 32 incl. sub-types Sub-types →
- Tertiary hyperparathyroidism 2 trials
-
Hypoparathyroidism 46 trials · 66 incl. sub-types
3 sub-types
- Hereditary hypoparathyroidism 0 trials · 26 incl. sub-types Sub-types →
- Autoimmune hypoparathyroidism 0 trials · 8 incl. sub-types Sub-types →
- Secondary hypoparathyroidism due to impaired parathormon secretion 0 trials
-
Tumor of parathyroid gland 3 trials · 46 incl. sub-types
3 sub-types
- Familial primary hyperparathyroidism 1 trial · 35 incl. sub-types Sub-types →
- Benign neoplasm of parathyroid gland 0 trials · 6 incl. sub-types Sub-types →
- Malignant tumor of parathyroid gland 2 trials · 6 incl. sub-types Sub-types →
-
Parathyroid hyperplasia 0 trials
Most studied deeper sub-types
-
Higher dose hormone therapy aims to control rare calcium disorder
Disease control Recruiting nowThis phase 3 trial tests higher daily doses (over 30 mcg) of palopegteriparatide (Yorvipath) in 36 adults with chronic hypoparathyroidism. Participants already on the drug will have their dose adjusted to find the best level for controlling calcium without needing extra vitamin D…
Phase 3 • Sponsor: Ascendis Pharma Bone Diseases A/S • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New light probe aims to prevent thyroid surgery complication
Disease control Recruiting nowThis study tests a device called PTeye™ that uses near-infrared light to help surgeons see and protect tiny parathyroid glands during total thyroid removal. About 210 adults in Hong Kong will be randomly assigned to standard surgery or PTeye™-assisted surgery. The goal is to see …
Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Glow-in-the-Dark probe could save parathyroid glands during thyroid surgery
Disease control Recruiting nowThis study tests whether a device called PTeye, which uses near-infrared light to make parathyroid glands glow, helps surgeons find and protect these tiny glands during thyroid surgery. The trial will compare outcomes in 154 patients who have their first total thyroidectomy, with…
Sponsor: Marcin Barczynski • Aim: Disease control
Last updated Jun 26, 2026 12:41 UTC
-
Parathyroid surgery may boost mobility in seniors
Knowledge-focused Recruiting nowThis study looks at whether removing the parathyroid gland can improve physical function and mobility in adults aged 60 and older with primary hyperparathyroidism. Researchers will track changes in walking, strength, and daily activity before and after surgery, and analyze blood …
Sponsor: University of Florida • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC